Mesopral

Esomeprazole, the active ingredient in Mesopral, is a proton pump inhibitor presented as an oral dosage form for systemic use. It reduces gastric acid production and is prescribed for conditions such as gastro‑oesophageal reflux disease, erosive esophagitis, peptic ulcer disease and Helicobacter pylori eradication regimens.

GNH USA supplies Mesopral as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for regulated markets. Our distribution network ensures timely delivery across Europe, Asia and the Americas.

Esomeprazole is indicated for several acid‑related disorders that involve excessive gastric acid secretion. - Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and regurgitation by maintaining higher gastric pH. - Erosive esophagitis: promotes healing of inflamed esophageal tissue and prevents further damage. - Peptic ulcer disease: supports ulcer resolution by reducing acid exposure to the gastric lining. - Helicobacter pylori eradication: enhances the effectiveness of antibiotic regimens used to eliminate H. pylori infection.

Esomeprazole may be associated with a range of adverse reactions, which are generally classified by frequency and severity.

Common Side Effects: - Headache: mild to moderate pain, often transient. - Diarrhea: loose stools, usually self‑limiting. - Nausea: feeling of sickness or upset stomach.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis that can occur with prolonged use. - Severe allergic reaction: rash, swelling, or anaphylaxis requiring immediate medical attention. - Low magnesium levels (hypomagnesemia): may cause muscle cramps, seizures or cardiac arrhythmias.

When prescribing or dispensing esomeprazole, several safety considerations should be observed. - Assess renal function: dose adjustment may be needed in severe renal impairment. - Use with caution in hepatic impairment: monitor for increased exposure. - Monitor magnesium: prolonged therapy can lead to hypomagnesemia; check levels periodically. - Evaluate need for long‑term use: limit duration to the shortest effective period to reduce risk. - Review concomitant medications: consider potential interactions that may affect efficacy or safety. - Store at room temperature: keep in the original container, protect from moisture and heat.

Esomeprazole can affect the plasma concentrations of several co‑administered drugs.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, may increase cardiovascular risk. - Atazanavir, nelfinavir, rilpivirine: decreased absorption leading to loss of antiviral efficacy.

Moderate Interactions (Monitor Closely): - Ketoconazole, itraconazole: reduced antifungal absorption; consider alternative dosing. - Iron salts: decreased iron absorption; separate administration by at least 2 hours. - Methotrexate (high dose): increased serum levels; monitor for toxicity.